Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Brentuximab vedotin in combination with or without donor lymphocyte infusion for patients with Hodgkin lymphoma after allogeneic stem cell transplantation.
Tsirigotis P, Danylesko I, Gkirkas K, Shem-Tov N, Yerushalmi R, Stamouli M, Avigdor A, Spyridonidis A, Gauthier J, Goldstein G, Apostolidis J, Mohty M, Shimoni A, Nagler A. Tsirigotis P, et al. Among authors: apostolidis j. Bone Marrow Transplant. 2016 Oct;51(10):1313-1317. doi: 10.1038/bmt.2016.129. Epub 2016 May 16. Bone Marrow Transplant. 2016. PMID: 27183095
Favorable Outcome After Adjuvant Involved-Field Radiotherapy After Autologous Hematopoietic Stem-Cell Transplantation in Patients With High-Risk Relapsed/Refractory Lymphoma: A Single-Center Experience.
Kaloyannidis P, Omari R, Eldebawy E, Al Shaibani E, Apostolidis J, Hindi T, Raslan H, Al Garni A, Al Buali A, Al Anezi K, Al Hashmi H. Kaloyannidis P, et al. Among authors: apostolidis j. Clin Lymphoma Myeloma Leuk. 2021 Feb;21(2):e112-e119. doi: 10.1016/j.clml.2020.08.028. Epub 2020 Sep 19. Clin Lymphoma Myeloma Leuk. 2021. PMID: 33060051
Incidence and risk factors for central nervous system relapse in patients with primary mediastinal large B-cell lymphoma in the rituximab era.
Vassilakopoulos TP, Panitsas F, Mellios Z, Apostolidis J, Michael M, Gurion R, Ferhanoglu B, Hatzimichael E, Karakatsanis S, Dimou M, Kalpadakis C, Katodritou E, Leonidopoulou T, Kotsianidis I, Giatra H, Kanellias N, Sayyed A, Tadmor T, Akay OM, Angelopoulou MK, Horowitz N, Bakiri M, Pangalis GA, Panayiotidis P, Papageorgiou SG. Vassilakopoulos TP, et al. Among authors: apostolidis j. Hematol Oncol. 2023 Feb;41(1):97-107. doi: 10.1002/hon.3096. Epub 2022 Dec 8. Hematol Oncol. 2023. PMID: 36314897
37 results